drugset / Trial / NCT06354270

A Clinical Study to Evaluate the Anti-Sensitivity Efficacy of a Stannous Fluoride Toothpaste in a Population of Dentin Hypersensitivity Sufferers

NCT06354270

Completed 115 enrolled HALEON
RandomizedParallel-groupSingle-blindTreatment

Summary

The aim of this study is to confirm the clinical Dentin Hypersensitivity (DH) efficacy of a 0.454 percent (%) Stannous Fluoride (SnF2) toothpaste.

Timeline

Start
2024-04-11
Primary completion
2024-06-23
Completion
2024-06-23

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fluoride Other / unclassified 1100 ppm Topical
Subject stannous fluoride Small molecule 0.454 % Topical

Indications